RA Capital Management portfolio

RA Capital Management (Investor) is known to hold 223 companies, 83 of them startups. 94 of them are hiring now, with 10,330 open roles. Its companies closed 31 venture rounds in 12 months, raising $2.4B. Most of them work in Health Care, Biotechnology, Artificial Intelligence.

Source: Alion Investor Nov 1, 2026
Investments
223
83 of them startups
Hiring now
94
10,330 open roles
Rounds in 12 months
31
$2.4B raised
Exits
93

Companies RA Capital Management has invested in

STAR Therapeutics Venture round $200M · this month portfolio pageOct 2
NexCure Oncology Therapeutics Series A $19M · this month portfolio pageOct 2
Optivolt United States Series A $32M · this month 1 role portfolio pageOct 2
Navigator Medicines Biologics & Biosimilars · United States Venture round $10M · 1 mo ago portfolio pageOct 2
Reframe Systems Construction Robotics · United States Venture round $40M · 1 mo ago 22 roles portfolio pageOct 2
Solstice Oncology Cell & Gene Therapy · United States Series A $225M · 1 mo ago portfolio pageOct 2
Typewriter Therapeutics Series A $56M · 1 mo ago portfolio pageOct 2
Ausperbio Biologics & Biosimilars · United States Series C $120M · 2 mo ago portfolio pageSep 25
Infinimmune Venture round $75M · 2 mo ago portfolio pageOct 2
Abcuro United States Venture round $39.4M · 2 mo ago portfolio pageSep 25
LifeMine Prescription Drugs · United States Venture round $263M · 2 mo ago 1 role portfolio pageOct 2
Alchemab Therapeutics Ltd Venture round · 4 mo ago portfolio pageSep 25
Celea Therapeutics Oncology Therapeutics · United States Venture round $180M · 4 mo ago 8 roles portfolio pageSep 25
Enara Bio Drug Discovery · United Kingdom Venture round · 4 mo ago 2 roles portfolio pageSep 25
Contra Line Console Games · United States Venture round $55.8M · 5 mo ago portfolio pageSep 25
Secretome Therapeutics Regenerative Medicine · United States Series A $30M · 5 mo ago 4 roles portfolio pageOct 2
Climb Bio United States Venture round $110.1M · 6 mo ago 5 roles portfolio pageSep 25
Terremoto Bio Drug Discovery · United States Venture round $40.7M · 6 mo ago portfolio pageOct 2
Stipple Venture round $65.1M · 7 mo ago portfolio pageOct 2
Pinnacle Medicines Drug Discovery Series B $89M · 7 mo ago portfolio pageOct 2
AN2 Therapeutics Infectious Disease Therapeutics · United States Venture round $40M · 7 mo ago portfolio pageSep 25
Terrestrial Cardiometabolic Therapeutics · United States Venture round $57.3M · 7 mo ago 12 roles portfolio pageOct 2
Slate Medicines Neurology & CNS Therapeutics · United States Series A $130M · 8 mo ago portfolio pageOct 2
Apeiron Labs United States Series A $9.5M · 8 mo ago portfolio pageSep 25
Kinaset Therapeutics United States Series B $103M · 9 mo ago portfolio pageOct 2
Atavistik Bio Prescription Drugs · United States Series B $120M · 10 mo ago 1 role portfolio pageSep 25
TRIANA Biomedicines, Inc. United States Series B $120M · 10 mo ago portfolio pageOct 2
Hemab Venture round $157M · 12 mo ago portfolio pageSep 25
Adagio Medical Health & Medical Electronics Venture round $19M · 12 mo ago portfolio pageSep 25
ADCytherix Series A $113.4M · 12 mo ago portfolio pageSep 25
Gameto Women’s Health & Maternity Series C $44M · 14 mo ago portfolio pageSep 25
Planted Solar Solar Energy · United States Venture round $12M · 15 mo ago 10 roles portfolio pageOct 2
PAhR Therapeutics Cardiometabolic Therapeutics Seed $14M · 15 mo ago portfolio pageOct 2
Sorteratechnologies Waste Management · United States Venture round $87M · 16 mo ago portfolio pageOct 2
Sydnexis Pediatric Care · United States Convertible Note $20M · 18 mo ago portfolio pageOct 2
Vivace Therapeutics Venture round $17.5M · 20 mo ago portfolio pageOct 2
Verdiva Bio Cardiometabolic Therapeutics Series A $410M · 21 mo ago portfolio pageOct 2
Synapticure Telemedicine & Virtual Care · United States Series A $25M · 23 mo ago 3 roles portfolio pageOct 2
Alentis Therapeutics Biologics & Biosimilars Series D $181.4M · 23 mo ago portfolio pageSep 25
Familiar Machines & Magic Robotics AI · United States Venture round $15M · 2 yr ago 2 roles portfolio pageSep 25
Aktis Oncology Venture round $175M · 2 yr ago 1 role portfolio pageSep 25
Koloma Hydrogen Energy · United States Convertible Note $61.4M · 2 yr ago portfolio pageOct 2
Outpacebio Cell & Gene Therapy · United States Venture round $56M · 2 yr ago portfolio pageOct 2
Element Biosciences Laboratory Equipment · United States Series D $277M · 2 yr ago 16 roles portfolio pageSep 25
Circle Pharma United States Venture round $92.4M · 2 yr ago portfolio pageSep 25
Altrubio Immunology & Inflammation Therapeutics · Taiwan Series B $225M · 2 yr ago portfolio page, round in the pressMay 21, 2024
TORL BioTherapeutics LLC United States Venture round $158.3M · 2 yr ago portfolio pageOct 2
Enliven Therapeutics Drug Discovery · United States Venture round $90M · 2 yr ago portfolio pageOct 2
BioAge Labs Drug Discovery · United States Venture round $194.4M · 2 yr ago 3 roles portfolio pageSep 26
AM Batteries Energy Storage · United States Series B $30M · 2 yr ago portfolio pageSep 25
Forward Therapeutics Venture round $50M · 2 yr ago portfolio pageSep 25
Lyra Therapeutics United States Venture round $50M · 3 yr ago portfolio pageOct 2
Boundless Bio United States Series C $100M · 3 yr ago portfolio pageSep 25
EvodiaBio Denmark Venture round $6.4M · 3 yr ago portfolio pageSep 25
Metagenomi Cell & Gene Therapy · United States Venture round $95.8M · 3 yr ago portfolio pageOct 2
Sperotherapeutics Venture round $9M · 3 yr ago portfolio pageOct 2
Empatica Venture round $25.9M · 4 yr ago 3 roles portfolio pageOct 2
Bellicum Venture round $35M · 4 yr ago portfolio pageSep 25
Genetixbiotx Cell & Gene Therapy · United States Venture round $75M · 5 yr ago 9 roles portfolio pageSep 25
Plantible Foods Food Ingredients · United States Venture round $26.8M · 5 yr ago 10 roles portfolio pageOct 2
GentiBio Cell & Gene Therapy · United States Series A $157M · 5 yr ago portfolio pageOct 2
Merck.com Prescription Drugs · United States Venture round $486 · 5 yr ago 3 roles portfolio pageSep 25
Frontiermeds Drug Discovery · United States Venture round $88.5M · 5 yr ago 3 roles portfolio pageSep 25
Synthekine Series B $107.5M · 5 yr ago portfolio pageOct 2
Somatus Dialysis & Kidney Care · United States Venture round $60.1M · 5 yr ago 1 role portfolio pageOct 2
Forge Biologics CRO & CDMO Services · United States Series B $120M · 5 yr ago 13 roles portfolio pageSep 25
Pyxis Oncology United States Venture round $172.5M · 5 yr ago portfolio pageOct 2
Tenaya Therapeutics Ammunition Series C $106M · 5 yr ago portfolio pageOct 2
Vorbio Immunology & Inflammation Therapeutics · United States Venture round $110.1M · 6 yr ago 1 role portfolio pageOct 2
Akouos Venture round $105.1M · 6 yr ago portfolio pageSep 25
Black Diamond Therapeutics Venture round $85M · 6 yr ago portfolio pageSep 25
Shockwave Medical United States Venture round $15M · 7 yr ago 1 role portfolio pageOct 2
Stoke Therapeutics Rare Disease Therapeutics · United States Venture round $90M · 8 yr ago 16 roles portfolio pageOct 2
Precision BioSciences Clinical Trial Services (CRO) · United States Venture round $88.1M · 8 yr ago portfolio pageOct 2
Obsidian Therapeutics Drug Discovery · United States Venture round $32.4M · 8 yr ago 7 roles portfolio pageOct 2
RxSight Ophthalmology & Eye Clinics · United States Venture round $50M · 9 yr ago 10 roles portfolio pageOct 2
C4 Therapeutics Drug Discovery · United States Venture round $70.3M · 10 yr ago 5 roles portfolio pageSep 25
Takeda Pharmaceutical Prescription Drugs · Japan 1071 roles portfolio pageOct 2
AbbVie Prescription Drugs · United States 1062 roles portfolio pageSep 25
Johnson & Johnson Prescription Drugs · United States 984 roles portfolio pageOct 2
Roche Prescription Drugs · Switzerland 723 roles portfolio pageSep 25
GSK Prescription Drugs · United Kingdom 720 roles portfolio pageSep 25
Sanofi Prescription Drugs · France 640 roles portfolio pageOct 2
AstraZeneca Prescription Drugs · United Kingdom 707 roles portfolio pageOct 2
Novartis Prescription Drugs · Switzerland 582 roles portfolio pageSep 25
Eli Lilly and Company Prescription Drugs · United States 490 roles portfolio pageSep 25
Bayer Prescription Drugs · Germany 336 roles portfolio pageOct 2
Pfizer Prescription Drugs · United States 315 roles portfolio pageSep 25
Alcon Surgical Instruments & Devices · Switzerland 235 roles portfolio pageOct 2
Gilead Sciences Prescription Drugs · United States 234 roles portfolio pageOct 2
Vertex Pharmaceuticals Prescription Drugs · United States 231 roles portfolio pageSep 25
Moderna Prescription Drugs · United States 201 roles portfolio pageOct 2
Ipsen Prescription Drugs · France 189 roles portfolio pageSep 25
Natera Genomics & Genetic Testing · United States 151 roles portfolio pageOct 2
UCB Biologics & Biosimilars · Belgium 146 roles portfolio pageOct 2
CSL Limited Biologics & Biosimilars · Australia 138 roles portfolio pageSep 25
Cortica Disability Support Services · United States 80 roles portfolio pageSep 25
Chiesi Prescription Drugs · Italy 74 roles portfolio pageOct 2
Thriveworks Psychiatric Care · United States 66 roles portfolio pageOct 2
Mirum Pharmaceuticals Prescription Drugs · United States 64 roles portfolio pageOct 2
123

Open roles at RA Capital Management portfolio companies

10,330 open roles at 94 of its companies

Focus

Markets
Health Care76%
Biotechnology36%
Artificial Intelligence6%
Energy & Utilities4%
Robotics3%
Manufacturing1%
Media & Entertainment1%
Education1%
Where its companies are
United States48%
United Kingdom2%
Switzerland1%
Canada1%
Denmark1%
Japan1%
France1%
Italy1%
Stage of its companies
Series C and later41%
Series B31%
Series A25%
Pre-seed & seed3%

Questions about RA Capital Management

How many companies has RA Capital Management invested in?

RA Capital Management is known to hold 223 companies: 83 startups, and 93 exits so far, read from its own portfolio page and the funding rounds that name it.

Is RA Capital Management investing now?

RA Capital Management has no round in the press in 12 months and no new company on its portfolio page in 90 days.

What does RA Capital Management invest in?

The markets of the companies RA Capital Management holds: Health Care (76%), Biotechnology (36%), Artificial Intelligence (6%), Energy & Utilities (4%), Robotics (3%).

Which RA Capital Management portfolio companies are hiring?

94 companies RA Capital Management holds are hiring now, with 10,330 open roles listed on this page.

Who does RA Capital Management invest alongside?

The investors that hold the most companies together with RA Capital Management: OrbiMed, Wellington Management, Foresite Capital, NEA, GV.

How this page is made

A company counts as a holding when the investor’s own portfolio page links to it, a program’s catalog lists it, or a funding round in the press names the investor. The numbers are rebuilt every night; each company shows where it came from and when it was first seen.

Sources: its portfolio page, read Oct 4; 1 rounds in the press that name it

RA Capital Management portfolio: 223 known companies. Alion, Nov 1, 2026. https://alion.io/company/ra-capital-management/portfolio

Licence: CC BY-SA 4.0JSON